Precursors of Stroke Incidence and Prognosis09/09/2023 - 08/31/2028 (Multi-PI)
PI:
Jose Rafael Romero, MDNIH/National Institute of Neurological Disorders & Stroke5R01NS017950-39
Longitudinal Risk Factor Changes and Early Recognition of Cerebral Small Vessel Disease09/25/2023 - 08/31/2025 (PI)
NIH/National Institute of Neurological Disorders & Stroke1R21NS135268-01
Enlarged Perivascular Spaces as Markers of Vascular and Alzheimer pathology: predictors, pathophysiology and clinical consequences08/01/2019 - 04/30/2025 (PI)
NIH/National Institute on Aging5R01AG059725-05
Precursors of Stroke Incidence and Prognosis09/09/2023 - 09/10/2023 (Multi-PI)
PI:
Jose Rafael Romero, MDNIH/National Institute of Neurological Disorders & Stroke2R01NS017950-38A1
Genetic Contribution to Brain Arterial Dilatation and its Role in Cognition and Dementia08/15/2018 - 04/30/2023 (Subcontract PI)
Trustees Of Columbia University In The City Of New York NIH NIA5R01AG057709-05
Precursors of Stroke Incidence and Prognosis12/01/2017 - 02/28/2023 (Subcontract PI)
University of Texas Health Science Center at San Antonio NIH NINDS5R01NS017950-37
Preclinical AD: Correlates of Amyloid, Tau PET and fcMRI in Framingham Gen 3 Young Adults12/01/2017 - 01/31/2021 (Subcontract PI)
University of Texas Health Science Center at San Antonio NIH NIA7R01AG049607-05
Cerebral Microbleeds in Young Adults: Risk Factors, Biomarkers and Genetic Determinants06/01/2015 - 05/31/2018 (PI)
NIH/National Institute on Aging5R03AG048180-02
Risk Factors, Genetics and Cognition in Cerebral Microbleeds: Framingham Study08/15/2011 - 05/31/2017 (PI)
NIH/National Institute on Aging5K23AG038444-05
Investigation of lipoprotein phospholipase A2 (Lp-PLA2) and cerebral microbleeds (CMBs) in the Framingham Heart Study11/01/2009 - 06/30/2011 (PI)
GlaxoSmithKline LLC
Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)04/01/2023 - 08/31/2026 (Subcontract PI)
PI:
Jose Rafael Romero, MDUniversity of Cincinnati NIH NINDS5U01NS117450-02
Sleep for Stroke Management and Recovery Trial (Sleep SMART)08/15/2019 - 07/31/2024 (Subcontract PI)
PI:
Jose Rafael Romero, MDUniversity of Cincinnati NIH NINDS5U01NS099043-02
Multi-arm Optimization of Stroke Thrombolysis (MOST) Stroke Trial-NCC Admin06/01/2018 - 04/30/2024 (Subcontract PI)
PI:
Jose Rafael Romero, MDUniversity of Cincinnati NIH NINDS1U01NS100699-01A1
New England Regional Coordinating Center for the NINDS Stroke Trials Network08/01/2018 - 07/31/2023 (Subcontract PI)
PI:
Jose Rafael Romero, MDThe General Hospital Corporation / MGH NIH NINDS1U24NS107243-01
New England Regional Coordinating Center for the NINDS Stroke Trials Network09/30/2013 - 05/31/2020 (Multi-PI)
PI:
Jose Rafael Romero, MDThe General Hospital Corporation / MGH NIH NINDS
CV006004
08/24/2016 - 07/01/2019 (PI)
Bristol-Myers Squibb Company
POINT Study: Platelet-Oriented Inhibition in New TIA02/01/2010 - 04/30/2019 (PI)
EMMES Corporation NIH-NINDS2U01NS062835-06
Mild and Rapidly improving stroke symptoms 'MaRISS' Research Study No. NEA-3104/01/2015 - 04/01/2019 (PI)
American Heart Association/AHA
New England Regional Coordinating Center for the NINDS Stroke Trials Network09/30/2013 - 07/31/2018 (PI)
Mass General Hosp NIH-NINDS